SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%

Morgan Stanley Maintains Underweight on Ionis Pharmaceuticals, Raises Price Target to $51

Morgan Stanley maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Underweight and raises the price target from $48 to $51.

Benzinga · 05/07/2020 12:38

Morgan Stanley maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Underweight and raises the price target from $48 to $51.